Metlife Inc [MET] stock is trading at $81.98, down -0.06%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MET shares have gain 0.80% over the last week, with a monthly amount glided 3.47%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Metlife Inc [NYSE: MET] stock has seen the most recent analyst activity on September 19, 2025, when Piper Sandler downgraded its rating to a Neutral but kept the price target unchanged to $84 for it. Previously, Wolfe Research started tracking the stock with Outperform rating on September 16, 2025, and set its price target to $95. On January 23, 2025, BMO Capital Markets initiated with a Market Perform rating and assigned a price target of $97 on the stock. TD Cowen started tracking the stock assigning a Buy rating and suggested a price target of $97 on October 09, 2024. Barclays initiated its recommendation with a Overweight and recommended $91 as its price target on September 05, 2024. Goldman upgraded its rating to Buy for this stock on January 08, 2024, but kept the price target unchanged to $80.
Metlife Inc [MET] stock has fluctuated between $65.21 and $89.05 over the past year. Currently, Wall Street analysts expect the stock to reach $93.5 within the next 12 months. Metlife Inc [NYSE: MET] shares were valued at $81.98 at the most recent close of the market. An investor can expect a potential return of 14.05% based on the average MET price forecast.
Analyzing the MET fundamentals
Metlife Inc [NYSE:MET] reported sales of 73.02B for the trailing twelve months, which represents a drop of -2.71%. Gross Profit Margin for this corporation currently stands at 0.27% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.08%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.15 and Total Capital is 0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 81.25 points at the first support level, and at 80.51 for the second support level. However, for the 1st resistance point, the stock is sitting at 82.99, and for the 2nd resistance point, it is at 83.99.
Ratios To Look Out For
For context, Metlife Inc’s Current Ratio is 4.34. Considering the valuation of this stock, the price to sales ratio is 0.75, the price to book ratio is 1.97 and price to earnings (TTM) ratio is 13.89.
Transactions by insiders
Recent insider trading involved Metlife 401(k) Plan Large cap, Affiliate discretionary manage, that happened on Oct 01 ’25 when 333.0 shares were purchased. Affiliate discretionary manage, Metlife 401(k) Plan Large cap completed a deal on Sep 19 ’25 to buy 269.0 shares. Meanwhile, Affiliate MetLife Separate Account SPI bought 221.0 shares on Sep 19 ’25.
